Drugs · acquisition-cost intelligence
AirDuo RespiClick
Fluticasone Propionate and Salmeterol· ingredient salmeterolAdrenergics in combination with corticosteroids or other drugs, excl. anticholinergics· FLUTICASONE PROPIONATE 113 ug/1; SALMETEROL XINAFOATE 14 ug/1; FLUTICASONE PROPIONATE 232 ug/1; SALMETEROL XINAFOATE 14 ug/1; FLUTICASONE PROPIONATE 55 ug/1; SALMETEROL XINAFOATE 14 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$110.30
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 7 weeks.
2025-06-182026-05-20
Same-ingredient options by acquisition cost
Other salmeterol products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| ADVAIR DISKUS | $1.33 | −$108.97 |
| ADVAIR DISKUS | $3.12 | −$107.17 |
| SEREVENT DISKUS | $6.74 | −$103.55 |
| Fluticasone Propionate and Salmeterol HFA | $20.32 | −$89.97 |
| ADVAIR HFA | $22.72 | −$87.58 |
Medicare Part D coverage · CY2026
On 101 plan formularies · typical tier 3
Prior auth 0% · Step therapy 0% · Quantity limit 89% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.